Recent evidence indicates that RAD18 promotes the stem-cell phenotype through the Hippo/YAP/TGF-β pathway, resulting in the activation of M2 tumor-associated macrophages in triple-negative breast cancer (Yan et al., 2022). This evidence concerns the gene TGFB1 and triple-negative breast carcinoma.